会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 33. 发明授权
    • Cosmetic composition for stimulating the synthesis of proteins of the basement membrane
    • 用于刺激基底膜蛋白质合成的化妆品组合物
    • US08722852B2
    • 2014-05-13
    • US13614337
    • 2012-09-13
    • Hugo ZieglerDominik ImfeldMartin StockliMarc Heidl
    • Hugo ZieglerDominik ImfeldMartin StockliMarc Heidl
    • C07K5/11
    • A61Q19/08A61K8/64C07K5/0815C07K5/1019
    • Cosmetic composition which can be applied topically, comprising at least one compound of the general formula (I) in which R1 is H, C1-C20-alkyl, cycloalkyl or aryl-C1-C4-alkyl, n is 1-4, X is —O—, —NH— or —NR2— and R2H or C1-C20-alkyl; and at least one compound corresponding to the above formula (I) but in which XR1 with X having the possible meaning of —NH— is the residue of an alpha-amino acid; use of these compounds and of the composition for stimulating the synthesis of the proteins of the basement membrane; and also both those compounds of the formula (I) in which X is —NR2— and both R1 and R2 are different from H, and the compounds corresponding to formula (I) but in which XR1 with X having the possible meaning of —NH— is the residue of an alpha-amino acid, as such.
    • 可以局部施用的化妆品组合物,其包含至少一种通式(I)的化合物,其中R 1是H,C 1 -C 20 - 烷基,环烷基或芳基-C 1 -C 4 - 烷基,n是1-4,X是 -O - , - NH-或-NR 2 - 和R 2 H或C 1 -C 20 - 烷基; 和至少一种对应于上述式(I)的化合物,但其中具有可能含义为-NH-的X的XR1为α-氨基酸的残基; 使用这些化合物和组合物刺激基底膜的蛋白质的合成; 以及其中X为-NR 2 - 且R 1和R 2不同于H的式(I)化合物以及对应于式(I)的化合物,但其中具有可能含义为-NH的X的XR1 - 是这样的α-氨基酸的残基。
    • 34. 发明授权
    • Method for producing 3-amidinophenylalanine derivatives
    • 制备3-脒基苯丙氨酸衍生物的方法
    • US08642761B2
    • 2014-02-04
    • US13300237
    • 2011-11-18
    • Hugo ZieglerPeter Wikstroem
    • Hugo ZieglerPeter Wikstroem
    • C07D241/04C07D211/34C07C307/02
    • C07D295/205C07D211/60
    • The present invention describes a method for the synthesis of enantiomerically pure 3-amidinophenylalanine derivatives, which are used as pharmaceutically effective urokinase inhibitors, by starting from 3-cyanophenylalanine derivatives. The methods of manufacture comprising only one synthesis step lead to new intermediates, namely 3-hydroxyamidino- and 3-amidrazonophenylalanine derivatives. These intermediates or their acetyl derivatives can be reduced into the desired 3-amidino-phenylalanine derivatives under gentle conditions (H2 or ammonium formiate, Pd/C (approx. 10%), ethanol/water, room temperature, normal pressure or also H2, Pd/C, AcOH or HCl/ethanol, 1-3 bar) in excellent yields and in an enantiomeric excess of up to 99.9%.
    • 本发明描述了通过从3-氰基苯丙氨酸衍生物开始合成用作药物有效的尿激酶抑制剂的对映体纯的3-脒基苯丙氨酸衍生物的方法。 仅包含一个合成步骤的制备方法导致新的中间体,即3-羟基脒基 - 和3-酰胺基苯丙氨酸衍生物。 这些中间体或其乙酰基衍生物可以在温和的条件下(H2或甲酸铵,Pd / C(约10%),乙醇/水,室温,常压或还有H2),还原成所需的3-脒基 - 苯丙氨酸衍生物, Pd / C,AcOH或HCl /乙醇,1-3巴),产率高达99.9%,对映异构体过量。
    • 36. 发明授权
    • Method for producing 3-amidinophenylalanine derivatives
    • 制备3-脒基苯丙氨酸衍生物的方法
    • US07884206B2
    • 2011-02-08
    • US11699228
    • 2007-01-29
    • Hugo ZieglerPeter Wikstroem
    • Hugo ZieglerPeter Wikstroem
    • C07D295/00C07D213/00
    • C07D295/205C07D211/60
    • The present invention describes a method for the synthesis of enantiomerically pure 3-amidinophenylalanine derivatives, which are used as pharmaceutically effective urokinase inhibitors, by starting from 3-cyanophenylalanine derivatives. The methods of manufacture comprising only one synthesis step lead to new intermediates, namely 3-hydroxyamidino- and 3-amidrazonophenylalanine derivatives. These intermediates or their acetyl derivatives can be reduced into the desired 3-amidinophenylalanine derivatives under gentle conditions (H2 or ammonium formiate, Pd/C (approx. 10%), ethanol/water, room temperature, normal pressure or also H2, Pd/C, AcOH or HCl/ethanol, 1-3 bar) in excellent yields and in an enantiomeric excess of up to 99.9%.
    • 本发明描述了通过从3-氰基苯丙氨酸衍生物开始合成用作药物有效的尿激酶抑制剂的对映体纯的3-脒基苯丙氨酸衍生物的方法。 仅包含一个合成步骤的制备方法导致新的中间体,即3-羟基脒基 - 和3-酰胺基苯丙氨酸衍生物。 这些中间体或其乙酰基衍生物可以在温和条件下(H2或甲酸铵,Pd / C(约10%),乙醇/水,室温,常压或还有H2,Pd / C,AcOH或HCl /乙醇,1-3巴),产率高,对映体过量高达99.9%。
    • 37. 发明授权
    • Method for producing 3-amidinophenylalanine derivatives
    • 制备3-脒基苯丙氨酸衍生物的方法
    • US07211670B2
    • 2007-05-01
    • US10506256
    • 2003-02-28
    • Hugo ZieglerPeter Wikstroem
    • Hugo ZieglerPeter Wikstroem
    • C07D241/04
    • C07D295/205C07D211/60
    • The present invention describes a method for the synthesis of enantiomerically pure 3-amidinophenylalanine derivatives, which are used as pharmaceutically effective urokinase inhibitors, by starting from 3-cyanophenylalanine derivatives. The methods of manufacture comprising only one synthesis step lead to new intermediates, namely 3-hydroxyamidino- and 3-amidrazonophenylalanine derivatives. These intermediates or their acetyl derivatives can be reduced into the desired 3-amidinophenylalanine derivatives under gentle conditions (H2 or ammonium formiate, Pd/C (approx. 10%), ethanol/water, room temperature, normal pressure or also H2, Pd/C, AcOH or HOI/ethanol, 1–3 bar) in excellent yields and in an enantiomeric excess of up to 99.9%.
    • 本发明描述了通过从3-氰基苯丙氨酸衍生物开始合成用作药物有效的尿激酶抑制剂的对映体纯的3-脒基苯丙氨酸衍生物的方法。 仅包含一个合成步骤的制备方法导致新的中间体,即3-羟基脒基 - 和3-酰胺基苯丙氨酸衍生物。 这些中间体或它们的乙酰基衍生物可以在温和条件(H 2 N 2或甲酸铵,Pd / C(约10%),乙醇/水,室温)下还原成所需的3-脒基苯丙氨酸衍生物, 正常压力,也可以是H 2 Cl 2,Pd / C,AcOH或HCl /乙醇,1-3巴),产率高,对映体过量高达99.9%。
    • 39. 发明授权
    • Urokinase inhibitors
    • 尿激酶抑制剂
    • US06861435B2
    • 2005-03-01
    • US10472367
    • 2002-03-19
    • Hugo Ziegler
    • Hugo Ziegler
    • C07D295/20A61K31/495A61K31/4965A61K45/00A61P17/00A61P35/00A61P35/04A61P43/00C07D295/215C07D207/06C07D207/10C07D295/04
    • C07D295/215A61K31/495
    • The invention relates to the compounds of general formula (I), that are present with respect to R1 as racemates as well as L- or D-configured compounds and as E/Z mixtures as well as E or Z isomers and in which the various symbols are defined as in the description and the claims, as well as to the salts thereof, for use as therapeutic agents and for diagnostic purposes. The inventive compounds can be processed to medicaments or to diagnostic agents that are used for the diagnosis, therapy and prevention of urokinase- or urokinase-receptor associated diseases, for example for the treatment of tumors. The compounds are highly efficient in inhibiting growth and/or spread of malign tumors, for example tumor spread of pancreatic cancer, tumor growth of breast cancer and the formation of tumor metastases. The compounds of formula (I) and the salts thereof can be produced by conventional methods.
    • 本发明涉及通式(I)的化合物,其相对于R 1为外消旋体以及L或D构型的化合物和作为E / Z混合物以及E或Z异构体存在,并且在 各种符号在说明书和权利要求书中被定义,以及其盐,用作治疗剂和用于诊断目的。 本发明化合物可以加工成用于诊断,治疗和预防尿激酶或尿激酶受体相关疾病的药物或诊断剂,例如用于治疗肿瘤。 这些化合物在抑制恶性肿瘤的生长和/或扩散方面是高效的,例如胰腺癌的肿瘤扩散,乳腺癌的肿瘤生长和肿瘤转移的形成。 式(I)化合物及其盐可以通过常规方法制备。